- Previous Close
50.74 - Open
50.20 - Bid 47.18 x --
- Ask 49.16 x --
- Day's Range
47.86 - 50.45 - 52 Week Range
47.86 - 88.65 - Volume
116,990 - Avg. Volume
517,701 - Market Cap (intraday)
17.89B - Beta (5Y Monthly) 1.07
- PE Ratio (TTM)
16.44 - EPS (TTM)
2.93 - Earnings Date May 28, 2025
- Forward Dividend & Yield 2.40 (3.13%)
- Ex-Dividend Date Feb 26, 2024
- 1y Target Est
74.20
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
elekta.comRecent News: 0O5H.IL
View MorePerformance Overview: 0O5H.IL
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0O5H.IL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0O5H.IL
View MoreValuation Measures
Market Cap
18.44B
Enterprise Value
23.72B
Trailing P/E
17.71
Forward P/E
11.57
PEG Ratio (5yr expected)
1.19
Price/Sales (ttm)
1.03
Price/Book (mrq)
1.71
Enterprise Value/Revenue
1.33
Enterprise Value/EBITDA
8.22
Financial Highlights
Profitability and Income Statement
Profit Margin
6.45%
Return on Assets (ttm)
4.91%
Return on Equity (ttm)
11.63%
Revenue (ttm)
17.37B
Net Income Avi to Common (ttm)
1.12B
Diluted EPS (ttm)
2.93
Balance Sheet and Cash Flow
Total Cash (mrq)
2.37B
Total Debt/Equity (mrq)
66.01%
Levered Free Cash Flow (ttm)
657.12M